Company

Restore Medical Ltd.

Restore Medical develops a catheter-delivered device for treating heart failure.

About

Founded in 2024, Restore Medical is developing ContraBand™, a transcatheter pulmonary artery banding system for patients with heart failure with reduced ejection fraction. It targets hospitals, cardiologists and other healthcare providers. Based in Or Yehuda, Israel, the company raised USD 23 mn in Series B funding in July 2025, co-led by Pitango HealthTech and the European Innovation Council, with Peregrine Ventures.

4Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in